Incidence and clinical characteristics of hypertriglyceridemic acute pancreatitis: A retrospective single-center study

Table 1 Clinical characteristics of hypertriglyceridemic acute pancreatitis

Characteristic	All (n = 371)
Sex, n (%)
Male	247 (66.6)
Female	124 (33.4)
Age, yr	39.86 ± 10.20
BMI (kg/m2)	25.99 ± 3.18
Causes, n (%)	203 (54.7)
Diet (high fatty acid)	127 (34.2)
Drinking (beer)	55 (14.8)
Mixed	21 (5.7)
Complications, n (%)
Diabetes mellitus	115 (31.0)
Hypertension	62 (16.7)
Fatty liver disease	336 (90.6)
Pregnancy	11 (3.0)
Recurrence, n (%)	122 (32.9)
Grades of severity, n (%)
MAP	63 (17.0)
MSAP	208 (56.1)
SAP	100 (26.9)
Improved Marshall score	1.30 ± 1.77
Organ failure, n (%)	117 (31.5)
MCTSI score	5.00 ± 1.83
Lipid-lowering treatment, n (%)
Intravenous insulin	144 (38.8)
HP	32 (8.6)
CRRT/HP + CRRT	77 (20.8)
Only anti-lipemic	118 (31.8)
Baseline TG, mg/dL	2544.59 ± 2305.37
Baseline AMY (nUNL)	5.00 ± 6.47
> UNL, n (%)	297 (80.1)
≥ 3UNL, n (%)	174 (46.9)
Admission to ICU, n (%)	126 (34.0)
Death, n (%)	11 (3.0)

BMI: Body mass index; MAP: Mild acute pancreatitis; MSAP: Moderately severe acute pancreatitis; SAP: Severe acute pancreatitis; MCTSI: Modified computed tomography severity index; HP: Hemoperfusion; CRRT: Continuous renal replacement therapy; TG: Triglyceride; AMY: Amylase; UNL: Upper limit of normal; ICU: Intensive care unit.